Correctional Settings. — Guam Code § 16111

§ 16111. Correctional Settings.

(a) In general. All correctional and detention settings shall

make the following information available to both correctional

staff and incarcerated individuals:

(1) The importance of emergency opioid antagonists in

preventing deaths from opioid overdoses;

(2) How to recognize the signs and symptoms of a drug

overdose;

(3) The essential steps in responding to a drug

overdose, including:

(A) Evaluate for signs of an opioid overdose;

(B) Call 911 for help;

(C) Administer an emergency opioid antagonist;

(D) Support the person’s breathing; and

(E) Monitor the person’s response.

(4) Where to obtain emergency opioid antagonists

throughout Guam;

(5) De-stigmatizing the possession of an emergency

opioid antagonist; and

(6) Guam laws limiting a person’s civil and criminal

liability for prescribing, distributing, or administering

emergency opioid antagonists.

(b) Training. Staff members, employees, and volunteers of

Guam correctional settings may take part in training offered

pursuant to §16108 of this Act.

(c) Storage. All correctional and detention settings are

hereby authorized to possess, stock, dispense, and administer

emergency opioid antagonists on their premises and shall keep

emergency opioid antagonists in stock pursuant to the prisoner

release program established in subsection (d) of this section.

(d) Risk management officer. All correctional and detention

settings shall designate a risk management officer to oversee the

possession, stocking, or administration of emergency opioid

antagonists on its premises.

(e) Prisoner release. At all correctional and detention

settings, on the day of an individual’s release from the correctional

or detention setting, correctional and detention staff are required

to:

(1) Offer an emergency opioid antagonist;

(2) Provide the individual with instructions on the use

of emergency opioid antagonists in the form of a written

pamphlet or other accessible instructional materials for an

individual with a disability;

(3) Require the individual to sign a written form

indicating that they have been give[n] the opportunity to

receive an emergency opioid antagonist; and

(4) Provide the individual with information regarding

where and how to obtain additional emergency opioid

antagonist doses locally.

(f) Amount. When offering an emergency opioid antagonist

to a soon-to-be-released incarcerated individual, the individual

shall be given as much of the emergency opioid antagonist as they

request and is available at the correctional setting.

(g) Purchase agreement. A correctional or detention setting

may enter into a purchase agreement with a private entity or

organization to purchase a supply of emergency opioid antagonists

for use pursuant to this section.